Skip to content

Psoas Tenotomy Under Ultrasound

Psoas Tenotomy Under Ultrasound

Status
Recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06064136
Acronym
TEPSe
Enrollment
15
Registered
2023-10-03
Start date
2025-12-31
Completion date
2026-09-30
Last updated
2025-12-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hip Injuries

Brief summary

The ilio-psoas conflict is a commonly accepted complication after total hip replacement, often linked to a mispositioning of the acetabular prosthetic component that conflicts with the ilio-psoas tendon. To correct these pains, a psoas tenotomy can be proposed. The results proven by the literature are very satisfactory. Psoas tenotomy is performed endoscopically, arthroscopically, or more rarely open. The contribution of echo surgery allows to limit the scar ransom but also to free itself from a complex infrastructure to the operating room including an arthroscopy column and an intraoperative fluoroscopy for a conventional tenotomy, This also saves procedural and installation time. No studies to date have described ultrasound-assisted psoas tenotomy Yhe investigators conducted a cadaveric study of the feasibility of psoas tenotomy under ultrasound that confirms the feasibility of this technique and the safety of the gesture for the surrounding anatomical structures. The objectives of this study are to assess the feasibility, pain and functional outcomes of ultrasound-assisted psoas tenotomy in patients with ilio-psoas conflict after total hip replacement.

Interventions

PROCEDUREPsoas tenotomy under ultrasound

Tenotomy of the ilio-psoas tendon under ultrasound is performed using an ultrasound machine, a 3 mm Acufex hook blade and a specific kit usually used for guided vertebroplasty and which allows the introduction of the Acufex hook blade atraumatically (foam end). The patient, under general anesthesia, is placed in supine position with the hip extending from 15 to 20°.

Sponsors

Centre Hospitalier Universitaire de Nice
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Patients 18 years of age or older * Indication of psoas tenotomy for ilio-psoas conflict after total hip replacement * Signature of the written informed consent form by the patient * Affiliation to a French health insurance scheme or equivalent Non Inclusion criteria: * Vulnerable people: pregnant or breast-feeding women (patients will undergo a pregnancy test: urinary test), adult under guardianship or deprived of freedom. * Allergies to local anesthetics * Patient on anticoagulant or antiplatelet agents * Contraindication to surgery * Refusal of patient involvement

Design outcomes

Primary

MeasureTime frameDescription
Evaluate the success rate of this new ultrasound-guided ilio-psoas tendon tenotomy technique3 weeks post-operativeThe success of this new ultrasound-guided ilio-psoas tendon tenotomy technique will be assessed by the disappearance of the ilio-psoas conflict after surgery. This criterion will be measured at the first control consultation

Secondary

MeasureTime frameDescription
Evaluate the Oxford Hip ScoreAt baseline, 3 weeks, 6 weeks, 3 and 6 months post-operativeThe Oxford Hip Score is a questionnaire that assesses pain and hip function of patients who have undergone total hip replacement surgery. Patient should reflect on their pain and functional abilities on the previous 4 weeks. The questionnaire is divided into 2 domains (pain and function), each domain being composed of 6 questions. For each question, 5 answers are possible, each with a score of 0 to 4 (None = 4, Minimal = 3, Slight = 2, Moderate = 1, Severe = 0). The total score ranges from 0 (most severe symptoms) to 48 (no symptoms).
Evaluate the Harris Hip ScoreAt baseline, 3 weeks, 6 weeks, 3 and 6 months post-operativeThe Harris Hip Score assess the results of hip surgery. It is composed of 10 questions divided into 4 domains (pain, function without deformation and amplitude of movements). A score is assigned to each response. The total score varies from 0 to 100. The higher the score, the better the results and the less dysfunctional the patient
Evaluation the Postel and Merle Aubigne scoreAt baseline, 3 weeks, 6 weeks, 3 and 6 months post-operativethe Postel and Merle Aubigne score measures pain, joint mobility and walking. For each question, 6 answers are possible, each one having a score of 0 to 6. The total score varies from 0 to 18, 18 indicating a perfect hip
Evaluate the technical difficulty of surgical procedurethe day after surgeryThe technical difficulty of surgical procedure will be assessed using a 4-point Likert scale: on the day of the operation, the surgeon will have to answer the question What was the difficulty experienced by you in the operation?. He may answer by: Very difficult, difficult, moderately difficult or easy.
Evaluate the operative timethe day of surgeryThe operative time will be expressed in minutes between skin incision and skin closure
Evaluate the installation timethe day of surgeryThe installation time will be expressed in minutes between the end of intubation and the beginning of the brush
Evaluate the total blood lossin the month before surgery and the day after surgeryTotal blood loss will be calculated according to the ostheo formula, including pre-operative (in the month preceding the surgery) and post-operative (the day after surgery) hematocrit values. This measure makes it possible to accurately assess the hidden blood losses related to the hematic extravasation
Evaluate the length of hospital staythe day after surgeryThe length of hospital stay will be expressed in hours, between the entry and the discharge of the patient
Evaluate the new ultrasound-guided ilio-psoas tendon tenotomy technique compared to standard practice on pain experienced by the patientPre-operative, 3 hours, 1 day, 3 weeks, 6 weeks, 3 and 6 months post-operativeThe pain felt by the patient will be collected using a numerical scale from 0 to 10 before surgery, 3 hours after surgery, the day after surgery, then 3 weeks, 6 weeks, 3 months and 6 months after surgery. Zero '0', means that the patient has no pain ; '10', means that the patient has extreme pain. The non-inferiority limit is set at 1.5 on the pain EVA scale
Evaluate the impact of the patient's quality of lifeAt baseline, 6 weeks, 3 and 6 months post-operativeQuality of life will be evaluated using the EuroQol five-dimension questionnaire (EQ-5D-5L), at inclusion, 6 weeks, 3 and 6 months after surgery.The EQ-5D-5L comprises a descriptive system and a visual analogue scale (VAS). The descriptive system is composed of five health dimensions (mobility, self-care, usual activities, pain/discomfort and anxiety/depression) with 5 levels of health (no problems, slight problems, moderate problems, severe problems and extreme problems). For each of the 5 dimensions, the participant's answer is converted to a number between 1 and 5, expressing the health state reported. The responses are combined to produce a five-digit number describing the participant's health status which is converted to a utility value from the country specific value set. The French EQ-5D-5L value set has utility between -0.530 (health condition worse than death) and 1 (best possible health). The VAS records the self-rated health status on a graduated scale from 0 to 100.
Evaluate the patient satisfaction with the results of the operation3 weeks, 6 weeks, 3 and 6 months post-operativePatient satisfaction will be assessed at 3 weeks, 6 weeks, 3 months and 6 months post-surgery using a 4-point Likert scale. To do this, the patient will have to answer the question: Are you satisfied with the results of your surgery?. They can answer with: very satisfied, satisfied, dissatisfied, or very dissatisfied.
Evaluate the subjective value of the hipat baseline, 3 weeks, 6 weeks, 3 and 6 months post-operativeThe subjective value of the hip will be assessed at inclusion, 3 weeks, 6 weeks, 3 months and 6 months after surgery by the patient himself. By answering the question What then is the overall percentage value of your hip if a completely normal hip equals 100%? , the patient should assess his hip on a scale of 0 to 100, 100 corresponding to a perfect hip.
Evaluate the forgotten hip sensation3 weeks, 6 weeks, 3 and 6 months post-operativeThe forgotten hip sensation will be assessed by the patient himself at 3 weeks, 6 weeks, 3 months and 6 months after surgery by answering the question Have you forgotten your hip?. The patient can answer yes or no.
Evaluate the Forgotten Hip score.at baseline, 6 weeks, 3 and 6 months post-operativeThe forgotten hip score will be assessed at inclusion, 6 weeks, 3 and 6 months after surgery. The score is composed of 12 questions assessing the degree of forgetfulness. For each question, the patient may respond with never, almost never, rarely, sometimes, often.
Evaluate the early (< 90 days) and late (> 90 days) surgical complications related to surgeryDuring 6 months after surgeryEarly complications (\< 90 days after surgery) and late complications (\> 90 days after surgery) will be sought the day after surgery and throughout the follow-up period. They will be classified as major (infections at the surgical site or medical complications increasing the length of hospitalization) or minor according to the series of the literature
Evaluate the rate of patient requiring a stay in a rehabilitation centerDuring 6 months after surgeryThe number of patients requiring rehabilitation will be collected for the duration of the study
Evaluate the scarring after surgery6 weeks post-operativeThe scarring after surgery will be evaluated at 6 weeks after surgery using a subjective scar satisfaction score (4-point Likert scale), transmitted by the patient himself. The patient will have to answer the question Are you satisfied with your scar?. He can answer: Very satisfied, satisfied, dissatisfied or very dissatisfied.

Countries

France

Contacts

Primary ContactGrégoire MICICOI
micicoi.g@chu-nice.fr0492036904

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026